Colon cancer in pregnancy

Cancer Control

Volumn 12, Issue 3, 2005, Pages 196-202

  Minter, Alex ^a   Malik, Rohit ^b   Ledbetter, Leslie ^a   Winokur, Thomas S ^a   Hawn, Mary T ^a   Saif, M Wasif ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Medical Center East   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CASE REPORT; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; PHYSICAL EXAMINATION; PREGNANCY; PREGNANCY TERMINATION; PROGNOSIS; SIGMOID; SYMPTOMATOLOGY;

EID: 23044488474     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480501200310     Document Type: Article

References (53)

1. Girard RM, Lamarche J, Baillot R. Carcinoma of the colon associated with pregnancy: report of a case. Dis Colon Rectum. 1981:24;473-475.
2. Cappell MS. Colon cancer during pregnancy, the gastroenterologist's perspective. Gastroenterol Clin North Am. 1998:27;225-256.
3. Bernstein MA, Madoff RD, Caushaj PF. Colon and rectal cancer in pregnancy. Dis Colon Rectum. 1993:36;172-178.
4. Nesbitt JC, Moise KJ, Sawyers JL. Colorectal carcinoma in pregnancy. Arch Surg. 1985:120;636-640.
5. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin. 1997:47;5-27.
6. Erratum in: CA Cancer J Clin. 1997:47;68.
7. Walsh C, Fazio VW. Cancer of the colon, rectum, and anus during pregnancy: the surgeon's perspective. Gastroenterol Clin North Am. 1998:27;257-267.
8. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med. 1988:148;2058-2064.
9. Woods JB, Martin JN Jr, Ingram FH, et al. Pregnancy complicated by carcinoma of the colon above the rectum. Am J Perinatal. 1992:9;102-110.
10. Isbister WH, Fraser J. Large-bowel cancer in the young: a national survival study. Dis Colon Rectum. 1990:33;363-366.
11. Francavilla A, Di Leo A, Polimeno L, et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding non cancerous colonic tissue. Gastroenterology. 1987:93;1301-1306.
12. Hendrickse CW, Jones CE, Donovan IA, et al. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg. 1993:80;636-640.
13. Xu X, Thomas ML. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol. 1994:105;197-201.
14. Slattery ML, Samowitz WS, Holden JA. Estrogen and progesterone receptors in colon tumors. Am J Clin Pathol. 2000:113;364-368.
15. Korenaga D, Orita H, Maekawa S, et al. Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer. Hepatogastroenterology. 1997:44;78-83.
16. Geelhoed GW, Alford C, Lippman ME. Biologic implications of steroid hormone receptors in cancers of the colon. South Med J. 1985:78;252-254.
17. Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 1997:91;197-208.
18. Majerus PW. Prostaglandins: critical roles in pregnancy and colon cancer. Curr Biol. 1998:8;R87-R89.
19. Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest. 1997:100;1325-1329.
20. Giovannucci E, Rimm EB, Stampfer MJ, et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994:121;241-246.
21. Balthazer EJ, Megibow AJ, Hulnick D, et al. Carcinoma of the colon: detection and preoperative staging by CT. AJR Am J Roentgenol. 1988:150;301-306.
22. Cappell MS. Gastrointestinal endoscopy in high risk patients. Dig Dis. 1996:14;228-244.
23. Melmed AD. Anesthesia principles and techniques in pregnancy. In: Cherr ST, Merkatz IR, eds. Complications of Pregnancy: Medical, Surgical, Gynecologic, Psychosocial, and Perinatal. 4th ed. Baltimore, Md: Williams and Wilkins: 1991.
24. Dark DS, Campbell DR, Wesselius LJ. Arterial oxygen desaturation during gastrointestinal endoscopy. Am J Gastroenterol. 1990:85;1317-1321.
25. Cappell MS, Colon VJ, Sidhom OA. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal in 83 pregnant females with follow-up of fetal outcome and with comparison control groups. Am J Gastroenterol. 1996:91;348-354.
26. Lamerz R, Ruider H. Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy. Bull Cancer. 1976:63;575-586.
27. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med. 1986:104;66-73.
28. Brent RL. Radiation teratogenesis. Teratology. 1980:21;281-298.
29. Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989:16;347-368.
30. Lees WR. Ultrasound of liver and spleen. In: Sutton D, Isherwood I, Forbes W, et al, eds. A Textbook of Radiology and Imaging. 5th ed. Edinburgh, NY: Churchill Livingstone; 1993.
31. Nies C, Leppek R, Sitter H, et al. Prospective evaluation of different diagnostic techniques for the detection of liver metastases at time of primary resection of colorectal carcinoma. Eur J Surg. 1996:162;811-816.
32. Seidman DS, Heyman Z, Ben-Ari GY, et al. Use of magnetic imaging in pregnancy to diagnose intussusception induced by colonie cancer. Obstet Gynecol. 1992:79;822-823.
33. Knoepp LF Jr, Ray JE, Overby I. Ovarian metastases from colorectal carcinoma. Dis Colon Rectum. 1973:16;305-311.
34. Mason MH 3rd, Kovalcik PJ. Ovarian metastases from colon carcinoma. J Surg Oncol. 1981:17;33-38.
35. Pitluk H, Poticha SM. Carcinoma of the colon and rectum in patients less than 40 years of age. Surg Gynecol Obstet. 1983:157;335-337.
36. Recalde M, Holyoke ED, Elias EG. Carcinoma of the colon, rectum and anal canal in young patients. Surg Gynecol Obstet. 1974:139;909-913.
37. Motwani BT, Shafir M, Merrick M, et al. Adenocarcinoma of the colon and rectum. In: Holland JF, Frei E III, Bast RC Jr, et al, eds. Cancer Medicine. 4th ed. Baltimore, Md: Williams & Wilkins; 1997.
38. Fleshman JW, Myerson RJ. Adjuvant radiation therapy for adenocarcinoma of the rectum. Surg Clin North Am. 1997:77;15-25.
39. Lashrop JC. Malignant pelvic lymphomas. Obstet Gynecol. 1967:30;137-145.
40. Weeks AE, Abbruzzese JL, Levin B. Current status of chemotherapy for colorectal cancer. Drug Ther (NY). 1989:19;36-55.
41. Grage TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Surg Clin North Am. 1981:61;1321-1329.
42. Higgins GA, Lee LE, Dwight RW, et al. The case for adjuvant 5-fluorouracil in colorectal cancer. Cancer Clin Trials. 1978:1;35.
43. MacDonald JS. Adjuvant therapy for colon cancer. CA Cancer J Clin. 1997:47;243-256.
44. Moertel CG, Fleming TR, MacDonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995:122;321-326.
45. Chabner BA, Allegra CJ, Curt GA et al. Antineoplastic agents. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, Health Professions Division; 1996.
46. Shuey DL, Buckalew AR, Wilke TS, et al. Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues. Teratology. 1994:50;379-386.
47. Sommers GM, Kao MS. Using chemotherapeutic agents during pregnancy. Contemp Obstet Gynecol. 1987:30;45-48.
48. Aviles A, Diaz-Maqueo JC, Talavera A, et al. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol. 1991:36;243-248.
49. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989:7;1447-1456.
50. Moertel CG, Fleming TR, MacDonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990:322;352-358.
51. Lipton LR, Johnson V, Cummings C, et al. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol. 2004;22:4934-4943.
52. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary non-polyposis colorectal cancer and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
53. Chan YM, Ngai SW, Lao TT. Colon cancer in pregnancy: a case report. J Reprod Med. 1999:44;733-736.